4/2/2008

Cleveland BioLabs has reported in a news release that its radiation drug, Protectan CBLB502, minimized blood damage after radiation exposure in primate studies. When the drug was administered 48 hours after exposure to radiation, survival rates increased.

Full Story:
Medical News Today

Related Summaries